Addition, Wang and his group found that RBP4 is overexpressed in ovarian cancer, and its overexpression promotes cancer the proliferation and metastasis of ovarian cancer cells via regulating RhoA/Rock1 pathway [30]. Here, RBP4 is linked to ovarian carcinoma.